APPLICATIONS PUBLISHED 23 JULY 2003
Published: 1-Jan-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 521 26 92
Methods of treating cystic fibrosis
Demegen 1328233*
Methods of decreasing or preventing pain using spicamycin derivatives
The General Hospital Corp 1328236*
Method for determining the release of a peptide from a sustained release polylactide formulation
AstraZeneca 1328520*
Methylphenidate modified release formulations
Celltech Manufacturing 1328251*
Transdermal pharmaceutical delivery compsn
Queen Mary and Westfield College 1328252*
Administration of a thiol-based chemoprotectant compound
Oregon Health Sciences University 1328253*
Lipid formulations for target delivery
The University of British Columbia 1328254*
Compsn and methods for stable injectable liquids
Cambridge Biostability 1328255*
Valve for osmotic devices
Alza Corp 1328256*
Biodegradable bioadhesive controlled release system of nanoparticles for oral care products
Salvona 1328257*
A controlled-release, parenterally administrable microparticle preparation
Jagotec 1328258*
Transdermal therapeutic systems comprising photosensitive active agents
LTS Lohmann Therapie-Systeme 1328259*
Methods and products related to pulmonary delivery of polysaccharides
Massachusetts Institute of Technology 1328260*
Treatment of neurodegenerative disease
Minerva Biotechnologies Corp 1328261*
A method to incorporate N-(4-hydroxyphenyl) retinamide in liposes
Board of Regents, The University of Texas System 1328262*
Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells
Sabinsa Corp 1328263*
Use of estramustine phosphate in the treatment of bone metastasis
Pharmacia & Upjohn 1328264*
Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions
Karo Bio 1328265*
Combination of fenofibrate and coenzyme Q10 for the treatment of endothelial dysfunction
Fournier Laboratories 1328266*
Method of treating cancer using dithiocarbamate derivatives
Charlotte-Mecklenburg Hospital Authority doing business as Carolinas Medical Center 1328267*
Combination of catechin and quercetin for pharmaceutical or dietary use
Guiliani 1328268*
Association of the CB1 receptor antagonist and sibutramin for treating obesity
Aventis Pharma 1328269*
Method for the treatment of neurological and neuropsychological disorders
Probiodrug 1328270*
Method for the treatment of neurological and neuropsychological disorders
Probiodrug 1328271*
NF-kappa-B inhibitors
SmithKline Beecham 1328272*
Felodipine transdermal device and methods
Euro-Celtique 1328273*
Compsns containing an inhibitor of dihydrofolate reductase and a folate
The UAB Research Foundation 1328274*
Substituted 4,5-dihydro-1,2,4-triazin-3-ones, 1,2,4-traizin-3-ones, and their use as fungicides and insecticides
Dow AgroSciences 1328275*
Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases
Schering 1328276*
Method for the preparation of a pharmaceutical compsn and its use
Schering 1328277*
Analgesic and glucosamine compsns
Temple University of the Commonwealth System of Higher Education 1328278*
Compsns comprising lignin and methods of making and using the same
Aquamed Technologies 1328279*
New compsn and method for the treatment of dysglucaemia
Metcon Medicin 1328280*
Compsn and methods for treating female sexual response
Qualife Pharmaceuticals 1328281*
Efficient method for producing compsns enriched in anthocyanins
Hauser; Tempesta, Michael S; Daugherty, F Joseph 1328282*
Skin external preparation containing pine pollen or pine pollen extract
Biolee 1328283*
Novel medicinal herbal compsn for treating liver diseases and HIV
Wu, Tzu-Sheng 1328284*
Oral preparation containing seaweed for reduction of plaque and calculus
SDC Swedencare 1328285*
Bone health compsns derived from milk
New Zealand Dairy Board 1328286*
Compsn and methods for WT1 specific immunotherapy
Corixa Corp; Gaiger, Alexander 1328287*
Protein mixtures for wound healing
Centerpulse Biologics 1328288*
Oxidised proteins, their biological activity, and therapeutic and diagnostic measures, which are derived from the active mechanism, from the use fo these proteins or from the inhibition thereof
Kehrel, Beate 1328289*
Expression, preparation, uses and sequence of recombinantly-derived soluble HLA-G
University of Kansas Medical Center 1328290*
Viruses targeted to hypoxic cells and tissues
Emory University 1328291*
Immunogenic compsns comprising liver stage malarial antigens
GlaxoSmithKline Biologicals 1328292*
Compsns and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
Sirbaski, David 1328293*
Combinations of acetylcholinesterase inhibitors or GABA-A inverse agonists for the treatment of cognitive disorders
Pfizer Products 1328294*
New interferon beta-like molecules
Maxygen Aps 1328295*
Camptothecin conjugates
SuperGen 1328296*
The function of a haptoglobin-haemoglobin receptor and the uses thereof
Proteopharma Aps 1328297*
Methods and compsns for modulating T-cell activation and uses thereof
The Scripps Research Institute 1328298*
